Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,414
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
for
Proliferative Diabetic Retinopathy (PDR)
Location: Baltimore MD, Monroeville PA, Chapel Hill NC,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18+
Code: NCT06790784
Phase3, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Columbia MD, York PA, Newark DE, White Plains NY,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Greenbelt MD, Baltimore MD, Hershey PA, Richmond VA,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase3, Recruiting
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
Location: Columbia MD, New York NY, Durham NC, Cleveland OH,
Sponsor: Karyopharm Therapeutics Inc
Sex: All
Age: 18+
Code: NCT05980806
Phase2, Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: Columbia MD, Westbury NY, Canton OH, Winston-Salem NC,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase3, Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Baltimore MD, Tappahannock VA, Newark DE, Richmond VA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06769126
Phase2, Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial